Boston Partners
- SEC CIK
- 0001386060
- Latest filing
- Aug 4, 2026
OVID holding history
Ovid Therapeutics Inc. in every 13F filed by Boston Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OVID overviewAll 13F holders of OVIDFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −77,003−100.0% | Sold out | Holders |
| Q1 2023 | 77,003 | $198.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 77,003 | $143.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 77,003 | $142.0K | <0.1% | +847+1.1% | Added | Holders |
| Q2 2022 | 76,156 | $164.0K | <0.1% | −8,105−9.6% | Reduced | Holders |
| Q1 2022 | 84,261 | $265.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 84,261 | $270.0K | <0.1% | +84,261 | New | Holders |